Category Archives: Stell Cell Research


In Bengaluru, a constellation if institutions – The Hindu

A fortuitous set of historical circumstances in Bengaluru has created a unique scientific and technological ecosystem. The nucleation of scientific research institutions in the city began with the founding of the Indian Institute of Science (IISc.) in 1909. It was a unique collaboration of private philanthropy [Jamsetji Nusserwanji Tata and the Nizam of Hyderabad] and support from the then Mysore Maharaja, together with advice from Nobel Laureate William Ramsey.

With a strong scientific leadership, like that of C.V. Raman and J. C. Ghosh, the institute steadily grew and nurtured a number of future science leaders of independent India, such as Homi J. Bhabha [who established cosmic ray research here and proceeded to build the Tata Institute of Fundamental Research]; Vikram Sarabhai [founder of the Indian Space Research Organisation], and Satish Dhawan [who played a major role at the National Aeronautical Laboratory and also headed ISRO], to name a few. IISc. also nurtured scientific stalwarts like Harish-Chandra and G. N. Ramachandran.

The countrys foremost referral centre for matters of the brain, the National Institute for Mental Health and Neurosciences (NIMHANS), has an equally long history.

The Bangalore Lunatic Asylum, founded in 1847 and rechristened as the Mysore Government Mental Hospital in 1925, became the first institute in India for postgraduate training in psychiatry. NIMHANS was born from the amalgamation of the mental hospital and the All-India Institute of Mental Health (AIIMH), established by the Union government in 1954.

Laboratories of the Defence Research and Development Organisation, and the Council of Scientific and Industrial Research are more recent entrants. The National Aeronautical Research Laboratory (NARL), set up at the stables of the palace of Maharaja of Mysore in Bengaluru, was converted into the National Aeronautical Laboratory under CSIR in 1960. It was further renamed the National Aerospace Laboratories (NAL) in 1993 to reflect its growing involvement in the Indian space programme.

Today, the list of research institutions in Bengaluru has grown to include the Raman Research Institute, the Indian Institute of Astrophysics, the Indian Statistical Institute, the Jawaharlal Nehru Centre for Advanced Scientific Research, three centres of TIFR (NCBS, CAM and ICTS), and more recently, the Institute for Stem Cell and Regenerative Medicine, to name just a few, all funded by various Union and State Science and Human Resource Departments.

Additionally, the presence of premier institutions in other professional disciplines, such as the National Law School of India University and the IIMB, have given Bengaluru a more rounded academic atmosphere. However, with the exception of the Institute for Social and Economic Change and the Indian Institute for Human Settlements, notably absent are long-lived institutions focused on Humanities.

Research centres like those above cannot thrive without having a feeder from undergraduate colleges.

Here again, Bengaluru, and for that matter Karnataka, has pioneered some fine undergraduate institutions and universities.

From public universities, such as the University Of Mysore and the Bangalore University, to private institutions, such as Manipal Academy of Higher Education, CHRIST (Deemed to be University) and more recently the Azim Premji University, the State has also promoted higher educational institutions.

Again, strong institutions from pre-Independence, like Science College (which later came under the Bangalore University), the 150-year-old Bangalore High School that gave rise to Central College, and the University Visvesvaraya College of Engineering (UVCE), set up by Sir M. Visvesvaraya, and Manipal University produced some accomplished students, who went on to shine in science and engineering at the international stage. IISc.s undergraduate programme in the sciences since 2009 has added a new dimension.

This constellation of institutions has created a name for Bengaluru as Indias science capital and renown on the international science scene as the home of a number of pioneering scientific ideas, discoveries and experiments.

A key ingredient in this success was political will. In the post-Independence era, strong political support for science and technology was crucial. Given the poverty and a low growth economy, such support was considered a wasteful expenditure by many. Bengaluru truly embraced the Nehruvian outlook of a self-reliant India, led by science.

This resulted in world-class institutions of excellence with support from both government and far-sighted philanthropists.

The strong scientific presence has also been a backbone for technological development. In the last 50 years, this ecosystem served the public sector with giants such as ITI, HMT, Bharat Electronics Limited (BEL), Bharat Heavy Electricals Limited (BHEL), and the aerospace industry, through the presence of ISRO as well as NAL and Hindustan Aeronautics Limited (HAL), reaping benefits of this human capital.

Since the late 1980s, private home-grown infotech and biotech industries [such as Infosys, Wipro, Biocon] and start-ups have also made Bengaluru their home, powered by the S&T institutions that produced highly skilled scientific and technical manpower.

Many international corporations have also set up R&D divisions here in the last couple of decades for the same reason. The State government has always been very forward in driving this synergy with the establishment of many Vision Groups in Information Technology, biotechnology, nanoscience, providing the necessary interface between the academic, industrial and government milieu.

Today, Bengaluru is also home to Indias most vibrant biotech start-up ecosystem, with State-supported Bangalore Bio Cluster, and the Bangalore Life Science Clusters Centre for Cell and Molecular Platforms (C-CAMP) as key players.

The city is perhaps unique in India to have created this ecosystem of institutions of scientific and technological excellence, which have had a broader impact on industry and society.

Worldwide, such concentrations of knowledge have driven wealth creation. Prominent examples are the Bay Area and Boston area in the U.S., and Cambridge in the U.K.

The question we need to be asking ourselves in 2020 is: given all the ingredients that Bengaluru has, where can we now take this? In the next 50 years, will it grow to be a global nervecentre for breakthroughs in STEM, which can hope to rival San Francisco or Boston? And if so, what is the pathway to getting there in the coming 50 years? Will this be sustainable? Are there new avenues for such an ecosystem to turn its focus to?

We feel Bengaluru can be a world science hub, given sustained efforts by all stakeholders. However, given the collaborative and transdisciplinary nature of contemporary science, our strategy should shift to coordinated engagement across institutions. Here, the recent announcement, by the Centre, of supporting geographical clusters takes significance.

If this coordination can take place, Bengaluru can mobilise its unique experience and chart out a brilliant future. Bengaluru is also home to a large number of NGOs working on environmental sustainability. Here too, new synergies are emerging: problems and solutions of sustainability require the coordination of many knowledge sources.

Bengaluru is also home to one of Indias fastest growing healthcare sectors.

There is a huge knowledge base in agriculture, with one of Indias best universities in this sector and many institutions that serve this critical sector. The gaze of Bengalurus multi-disciplinary scientific capital should look at these new opportunities, so that in the next few decades Karnataka will also be known for a transformative innovation in healthcare and agriculture as well as in environmental sustainability. Along with its core strengths in the basic sciences today, which must be deepened further, this can be an unbeatable combination.

(Rajesh Gopakumar and Satyajit Mayor are Centre Directors of the International Centre for Theoretical Sciences and the National Centre for Biological Sciences, respectively.)

Read more:
In Bengaluru, a constellation if institutions - The Hindu

Global Medical Thawing System Market 2020 with COVID-19 After Effects Analysis by Top Key Players | Helmer Scientific, Sarstedt, Sartorius, Biocision,…

Medical Thawing System Industry Overview Competitive Analysis, Regional and Global Analysis, Segment Analysis, Market Forecasts 2026

The new report on the globalMedical Thawing System marketpublished by theMarket Research Storeincorporates all the essential facts about the Medical Thawing System market. This aids different industry players along with new market entrants to open new gateways for the Medical Thawing System market on a global platform. Through in-depth research and data obtained from the reliable database the qualitative and the quantitative data of the Medical Thawing System market has been updated based on the current market conditions owing toCOVID-19. The overall market conditions have been affected due to the pandemic. The trading conditions and the economy crisis have affected the Medical Thawing System market. The information in the Medical Thawing System market report is updated and precise thus the clients will be able to relate themselves to the current market scenario.

Request Free Sample Copy of Medical Thawing System Market Research Report@http://www.marketresearchstore.com/report/global-medical-thawing-system-market-report-2018-industry-383588#RequestSample

The Medical Thawing System market report also encompasses the details about all the market players that are operating in the Medical Thawing System market. The market players includeHelmer Scientific, Sarstedt, Sartorius, Biocision, Boekel Scientific, Barkey, Cardinal Health, GE Healthcare, Thermo Fisher Scientific, Cytotherm.

The market analysis in the Medical Thawing System market study starts with the market definition and scope. In the next section, there is a brief discussion about the target audience of the market. In the later section, a detailed information about the market growth factors and limitations are discussed along with the market opportunities and challenges that are being faced owing to arise of the pandemic. Research tools and methodologies were used while analyzing the Medical Thawing System market.

Read Detailed Index of full Research Study at::http://www.marketresearchstore.com/report/global-medical-thawing-system-market-report-2018-industry-383588

The major section that covers the overall market description is the market segmentation. The Medical Thawing System market includes segments{Blood, Embryo, Ovum, Semen, Other Samples}; {Blood Banks & Transfusion Centers, Hospitals & Diagnostic Laboratories, Cord Blood & Stem Cell Banks, Research & Academic Institutes, Biotechnology & Pharmaceutical Companies, Tissue Banks}. To study any market in detail the major components that need to be analyzed are its product type, application, end-use, the solution and the services that are offered. Details about all these segments helps better understand the market size and demand. Every aspect of every single segment was studied carefully and the impact of COVID-19 was also taken into consideration. Both numerical data and subjective information about every segment is included for better understanding. The regional presence of the Medical Thawing System market is also included. The current market condition in each regions is explained thoroughly as to how the pandemic has affected the Medical Thawing System market demand in a particular region.

Major Advantages for Medical Thawing System Market:

1. Well-organized description of the international Medical Thawing System market along with the ongoing inclinations and future considerations to reveal the upcoming investment areas. 2. The all-inclusive market feasibility is examined to figure out the profit-making trends to obtain the most powerful foothold in the Medical Thawing System industry. 3. The Medical Thawing System market report covers data which reveal major drivers, constraints, and openings with extensive impact analysis. 4. The current market is quantitatively reviewed from 2019 to 2028 to pinpoint the monetary competency of the global Medical Thawing System market. 5. Last but not least, PORTERS Five Forces Analysis shows the effectiveness of the customers and providers from a global perspective.

If Any Inquiry of Medical Thawing System Report:http://www.marketresearchstore.com/report/global-medical-thawing-system-market-report-2018-industry-383588#InquiryForBuying

See original here:
Global Medical Thawing System Market 2020 with COVID-19 After Effects Analysis by Top Key Players | Helmer Scientific, Sarstedt, Sartorius, Biocision,...

Bone Allograft and Xenograft Market Size, Growth Trends, Top Players, Application Potential and Forecast to 2025 – Cole of Duty

The latest research report on the Bone Allograft and Xenograft market is an in-depth examination of this business sphere and is inclusive of information pertaining to vital parameters of the industry. The report provides details about the prevailing market trends, market share, industry size, current renumeration, periodic deliverables, and profits projections over the forecast timeframe.

Request a sample Report of Bone Allograft and Xenograft Market at:https://www.marketstudyreport.com/request-a-sample/2482193?utm_source=coleofduty.com&utm_medium=SP

An elaborate documentation of the Bone Allograft and Xenograft market performance during the analysis period is entailed in the report. Insights regarding the driving factors which will influence the market dynamics, alongside the growth pattern followed by the industry over the forecast period are presented. The report further focusses on analyzing the challenges existing in the market and growth prospects which define the business vertical over the forthcoming years.

Key highlights of the Bone Allograft and Xenograft market report:

Revealing the geographical landscape of the Bone Allograft and Xenograft market:

Summary of regional analysis presented in the Bone Allograft and Xenograft market report:

An exhaustive survey of Bone Allograft and Xenograft market with respect to product type and application scope:

Product scope:

Product types: Allografts and Xenografts

Major pointers mentioned in the report:

Ask for Discount on Bone Allograft and Xenograft Market Report at:https://www.marketstudyreport.com/check-for-discount/2482193?utm_source=coleofduty.com&utm_medium=SP

Application scope:

Application segmentation: Spinal Fusion, Bone Trauma and Others

Insights entailed in the report:

Other takeaways from the Bone Allograft and Xenograft market report:

Elucidating details about the competitive topography of the Bone Allograft and Xenograft market:

Prominent players of the industry: DePuy, Medtronic, Wright Medical, Geistlich, Zimmer Biomet, Xtant Medical and Arthrex

Key parameters included in the report which define the competitive landscape:

The Bone Allograft and Xenograft market report also emphasizes on major industry aspects like market concentration ratio.

For More Details On this Report:https://www.marketstudyreport.com/reports/global-bone-allograft-and-xenograft-market-growth-2020-2025

Some of the Major Highlights of TOC covers:

Development Trend of Analysis of Bone Allograft and Xenograft Market

Marketing Channel

Market Dynamics

Methodology/Research Approach

Related Reports:

1. Global Adipose Derived Stem Cell Therapy Market Growth (Status and Outlook) 2020-2025 Adipose Derived Stem Cell Therapy market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability. The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market. Read More: https://www.marketstudyreport.com/reports/global-adipose-derived-stem-cell-therapy-market-growth-status-and-outlook-2020-2025

2. Global Addisona??s Disease Drugs Market Growth (Status and Outlook) 2020-2025 Addisona??s Disease Drugs Market report characterize imperative Portion and contenders of the market regarding market estimate, volume, esteem. This report likewise covers every one of the locales and nations of the world, which demonstrates a territorial improvement status, it additionally incorporates Business Profile, Introduction, Revenue and so on. Read More: https://www.marketstudyreport.com/reports/global-addison-s-disease-drugs-market-growth-status-and-outlook-2020-2025

Read More Reports On: https://www.marketwatch.com/press-release/at-68-cagr-direct-methanol-fuel-cells-market-size-set-to-register-1488-million-usd-by-2025-2020-06-17

Contact Us: Corporate Sales, Market Study Report LLC Phone: 1-302-273-0910 Toll Free: 1-866-764-2150 Email: [emailprotected]

Read more:
Bone Allograft and Xenograft Market Size, Growth Trends, Top Players, Application Potential and Forecast to 2025 - Cole of Duty

Stem Cell Therapy Market Analysis On Trends & Need 2025 3w Market News Reports – 3rd Watch News

Global Stem Cell Therapy Market: Overview

Also called regenerative medicine, stem cell therapy encourages the reparative response of damaged, diseased, or dysfunctional tissue via the use of stem cells and their derivatives. Replacing the practice of organ transplantations, stem cell therapies have eliminated the dependence on availability of donors. Bone marrow transplant is perhaps the most commonly employed stem cell therapy.

Osteoarthritis, cerebral palsy, heart failure, multiple sclerosis and even hearing loss could be treated using stem cell therapies. Doctors have successfully performed stem cell transplants that significantly aid patients fight cancers such as leukemia and other blood-related diseases.

Know the Growth Opportunities in Emerging Markets

Global Stem Cell Therapy Market: Key Trends

The key factors influencing the growth of the global stem cell therapy market are increasing funds in the development of new stem lines, the advent of advanced genomic procedures used in stem cell analysis, and greater emphasis on human embryonic stem cells. As the traditional organ transplantations are associated with limitations such as infection, rejection, and immunosuppression along with high reliance on organ donors, the demand for stem cell therapy is likely to soar. The growing deployment of stem cells in the treatment of wounds and damaged skin, scarring, and grafts is another prominent catalyst of the market.

On the contrary, inadequate infrastructural facilities coupled with ethical issues related to embryonic stem cells might impede the growth of the market. However, the ongoing research for the manipulation of stem cells from cord blood cells, bone marrow, and skin for the treatment of ailments including cardiovascular and diabetes will open up new doors for the advancement of the market.

Global Stem Cell Therapy Market: Market Potential

A number of new studies, research projects, and development of novel therapies have come forth in the global market for stem cell therapy. Several of these treatments are in the pipeline, while many others have received approvals by regulatory bodies.

In March 2017, Belgian biotech company TiGenix announced that its cardiac stem cell therapy, AlloCSC-01 has successfully reached its phase I/II with positive results. Subsequently, it has been approved by the U.S. FDA. If this therapy is well- received by the market, nearly 1.9 million AMI patients could be treated through this stem cell therapy.

Another significant development is the granting of a patent to Israel-based Kadimastem Ltd. for its novel stem-cell based technology to be used in the treatment of multiple sclerosis (MS) and other similar conditions of the nervous system. The companys technology used for producing supporting cells in the central nervous system, taken from human stem cells such as myelin-producing cells is also covered in the patent.

The regional analysis covers:

Order this Report TOC for Detailed Statistics

Global Stem Cell Therapy Market: Regional Outlook

The global market for stem cell therapy can be segmented into Asia Pacific, North America, Latin America, Europe, and the Middle East and Africa. North America emerged as the leading regional market, triggered by the rising incidence of chronic health conditions and government support. Europe also displays significant growth potential, as the benefits of this therapy are increasingly acknowledged.

Asia Pacific is slated for maximum growth, thanks to the massive patient pool, bulk of investments in stem cell therapy projects, and the increasing recognition of growth opportunities in countries such as China, Japan, and India by the leading market players.

Global Stem Cell Therapy Market: Competitive Analysis

Several firms are adopting strategies such as mergers and acquisitions, collaborations, and partnerships, apart from product development with a view to attain a strong foothold in the global market for stem cell therapy.

Some of the major companies operating in the global market for stem cell therapy are RTI Surgical, Inc., MEDIPOST Co., Ltd., Osiris Therapeutics, Inc., NuVasive, Inc., Pharmicell Co., Ltd., Anterogen Co., Ltd., JCR Pharmaceuticals Co., Ltd., and Holostem Terapie Avanzate S.r.l.

About TMR Research:

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in todays supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Continue reading here:
Stem Cell Therapy Market Analysis On Trends & Need 2025 3w Market News Reports - 3rd Watch News

2025 Projeaction: Cancer Stem Cell Market 2020 Industry Research, Segmentation, Key Players Analysis and Forecast to 2025 – Cole of Duty

This report additionally covers the effect of COVID-19 on the worldwide market. The pandemic brought about by Coronavirus (COVID-19) has influenced each part of life all inclusive, including the business segment. This has brought along a several changes in economic situations.

A report on Cancer Stem Cell market compiled by Brand Essence Market Research provides a succinct analysis regarding the values and trends existing in the current business scenario. The study also offers a brief summary of market valuation, market size, regional outlook and profit estimations of the industry. Furthermore, the report examines the competitive sphere and growth strategies of leading players in the Cancer Stem Cell market. Download Premium Sample of the Report: https://industrystatsreport.com/Request/Sample?ResearchPostId=476&RequestType=Sample

TheMajorPlayersCovered in this Report:Thermo Fisher Scientific, Inc., AbbVie, Inc., Merck KGaA, Bionomics, LONZA, Stemline Therapeutics, Inc, Miltenyi Biotec, PromoCell GmbH, MacroGenics, Inc., ONCOMED PHARMACEUTICALS INC, Irvine Scientific, STEMCELL Technologies Inc, Sino Biological Inc, BIOTIME, INC., Others & More.

Reports include the following segmentation: By Type:Treatment Typeo Autologous Stem Cell Transplantso Allogeneic Stem Cell Transplantso Syngeneic Stem Cell Transplantso Bone Marrow Stem Cell TransplantsDisease Typeo Breast Cancero Blood Cancero Lung Cancero Brain Cancero Colorectal Cancero Pancreatic Cancero Bladder Cancero Liver Cancero OthersBy End-Use:Hospitals and Surgical CentresPharmaceutical and Biotech CompaniesCell Banks and Tissue BanksAcademic Institutes, Research Laboratories, and CROsOthersBy RegionNorth Americao U.S.o Canadao MexicoEuropeo UKo Franceo Germanyo Russiao Rest of EuropeAsia-Pacifico Chinao South Koreao Indiao Japano Rest of Asia-PacificLAMEAo Latin Americao Middle Easto Africa

Results of the recent scientific undertakings towards the development of new Cancer Stem Cell products have been studied. Nevertheless, the factors affecting the leading industry players to adopt synthetic sourcing of the market products have also been studied in this statistical surveying report. The conclusions provided in this report are of great value for the leading industry players. Every organization partaking in the global production of the Cancer Stem Cell market products have been mentioned in this report, in order to study the insights on cost-effective manufacturing methods, competitive landscape, and new avenues for applications.

Global Cancer Stem CellMarket: Regional Segmentation For further clarification, analysts have also segmented the market on the basis of geography. This type of segmentation allows the readers to understand the volatile political scenario in varying geographies and their impact on the global Cancer Stem Cellmarket. On the basis of geography, the global market for Cancer Stem Cellhas been segmented into:

North America(United States, Canada, and Mexico) Europe(Germany, France, UK, Russia, and Italy) Asia-Pacific(China, Japan, Korea, India, and Southeast Asia) South America(Brazil, Argentina, Colombia, etc.) Middle East and Africa(Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

Grab Your Report at an Impressive Discount @ https://industrystatsreport.com/Request/Sample?ResearchPostId=476&RequestType=Methodology

Report Methodology:

The information enclosed in this report is based upon both primary and secondary research methodologies.

Primary research methodology includes the interaction with service providers, suppliers, and industry professionals. Secondary research methodology includes a meticulous search of pertinent publications like company annual reports, financial reports, and exclusive databases.

Table of Content:

Market Overview: The report begins with this section where product overview and highlights of product and application segments of the Global Cancer Stem Cell Market are provided. Highlights of the segmentation study include price, revenue, sales, sales growth rate, and market share by product.

Competition by Company: Here, the competition in the Worldwide Global Cancer Stem Cell Market is analyzed, By price, revenue, sales, and market share by company, market rate, competitive situations Landscape, and latest trends, merger, expansion, acquisition, and market shares of top companies.

Company Profiles and Sales Data: As the name suggests, this section gives the sales data of key players of the Global Cancer Stem Cell Market as well as some useful information on their business. It talks about the gross margin, price, revenue, products, and their specifications, type, applications, competitors, manufacturing base, and the main business of key players operating in the Global Cancer Stem Cell Market.

Market Status and Outlook by Region: In this section, the report discusses about gross margin, sales, revenue, production, market share, CAGR, and market size by region. Here, the Global Cancer Stem Cell Market is deeply analyzed on the basis of regions and countries such as North America, Europe, China, India, Japan, and the MEA.

Application or End User: This section of the research study shows how different end-user/application segments contribute to the Global Cancer Stem Cell Market.

Market Forecast: Here, the report offers a complete forecast of the Global Cancer Stem Cell Market by product, application, and region. It also offers global sales and revenue forecast for all years of the forecast period.

Research Findings and Conclusion: This is one of the last sections of the report where the findings of the analysts and the conclusion of the research study are provided.

About Us:

We publish market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students.

Top Trending Reports:

https://www.marketwatch.com/press-release/global-armored-vehicles-market-size-share-application-analysis-regional-outlook-growth-trends-key-players-and-competitive-strategies-forecast-to-2025-2020-06-17?tesla=y

https://www.marketwatch.com/press-release/europe-microcontroller-market-size-share-growth-companies-industry-report-2020-2025-2020-06-17?tesla=y

https://www.marketwatch.com/press-release/chromatography-resin-market-2020-market-2020-by-key-features-advancements-companies-profile-industry-verticals-development-rapid-growth-and-business-strategy-2025-2020-06-09

https://www.marketwatch.com/press-release/at-cagr-of-33-bio-plasticizers-market-2020-size-sharetypes-applications-forecast-and-covid-19-impact-analysis-2025-2020-06-09

Read the original here:
2025 Projeaction: Cancer Stem Cell Market 2020 Industry Research, Segmentation, Key Players Analysis and Forecast to 2025 - Cole of Duty

Stem Cell Banking Market Overview and Regional Outlook with Research Study 2019 2026 – Cole of Duty

The global Stem Cell Banking Market size will rise at a considerable rate in the coming years. Driven by recent advancements in the material associated with manufacturing of the product, the market will rise at a rapid pace. According to a report by Fortune Business Insights, titled Global Stem Cell Banking Market Is Expected to Reach Around USD 13.36 Billion By 2025, the market will derive growth from recent product advancements.

Stem Cell Banking Market report provides a thoroughly researched abstract of the key players with considerable shareholdings at a global level regarding demand, sales, and income by providing better products and services. Research Report outlines a forecast for theStem Cell Banking Marketbetween 2020 and 2027. In terms of value, the Stem Cell Banking Market is expected to register a steady CAGR during the forecast period.

Get Sample PDF [emailprotected]https://www.zionmarketresearch.com/requestbrochure/stem-cell-banking-market

The research report provides a big picture on Stem Cell Banking Market 2027, on a global basis, offering a forecast and statistic in terms of revenue during the forecast period. This report covers detailed segmentation, complete R & D history, and explanatory analysis including the latest news. Furthermore, the study explains the future opportunities and a sketch of key players involved in theStem Cell Banking Marketin terms of revenue.

The Leading Market Players Covered in this Report are:

Cord Blood Registry (CBR) Systems, Cordlife Group Limited, Cryo-Cell International, ViaCord, Cryo-Save, LifeCell International, StemCyte, Global Cord Blood Corporation, Vita34, Smart Cells International, and CryoHoldco

This Research Help Grow Your Business [Download Sample PDF Of Research Report]

The scope of the Report:

The research report on global Stem Cell Banking Market includes segmentation on the basis of technology, application, end users, and region. Each segmentation is a chapter, which explains relevant components. The chapters include graphs to explain the year-on-year progress and the segment-specific drivers and restraints. In addition, the report also provides the government outlooks within the regional markets that are impacting the global Stem Cell Banking Market.

Global Stem Cell Banking Market: Segment Analysis

The globalStem Cell Banking Marketis segmented on the basis of technology, products, services, and applications. The segmentation is intended to give the readers a detailed understanding of the global market and the essential factors comprising it. This allows giving a better description of the drivers, restraints, threats, and opportunities. It also notes down socio-economic factors that are impacting the trajectory of the globalStem Cell Banking Market.

Inquire More about Report:https://www.zionmarketresearch.com/inquiry/stem-cell-banking-market

Global Stem Cell Banking Market: Regional Analysis Different regions of the global market influence growth differently. Various factors such as economic growth, technological developments, government policies, availability of labor, and others are compared with each to determine which region will outperform other. The regions included in this report are North America, Europe, Asia Pacific, and the Middle East and Africa.

Global Stem Cell Banking Market: Competitive Landscape

Competitive landscape of a report determines the overall scenario of the market focusing on key players and their strategic moves. Readers can get an insight of how various key players are performing in the market and the scope for emerging players.

Strategic Points Covered in TOC:

Chapter 1:Introduction, market driving force product scope, market risk, market overview, and market opportunities of the globalStem Cell Banking Market Chapter 2:Evaluating the leading manufacturers of the globalStem Cell Banking Marketwhich consists of its revenue, sales, and price of the products

Chapter 3:Displaying the competitive nature among key manufacturers, with market share, revenue, and sales

Chapter 4:Presenting globalStem Cell Banking Marketby regions, market share and with revenue and sales for the projected period

Chapter 5, 6, 7, 8 and 9:To evaluate the market by segments, by countries and by manufacturers with revenue share and sales by key countries in these various regions

Browse Full Report:https://www.zionmarketresearch.com/report/stem-cell-banking-market

Else place an Inquire before Purchase Global Stem Cell Banking Market Size, Status and Forecast 2027:

Worldwide Stem Cell Banking Market Report Provides Comprehensive Analysis of:

The classification of the global Stem Cell Banking Market is done based on the product type, segments, and end-users. The report provides an analysis of each segment together with the prediction of their development in the upcoming period. Additionally, the latest research report studies various segments of the global Stem Cell Banking Market in the anticipated period.

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

Note In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.

(*If you have any special requirements, please let us know and we will offer you the report as you want.)

Continue reading here:
Stem Cell Banking Market Overview and Regional Outlook with Research Study 2019 2026 - Cole of Duty

15 Biotech Companies In Houston To Know – Built In

Houston has played a significant role in boosting the nations biotech industry. While Houston is still a hotspot for energy and oil, the city is steadily becoming a burgeoning life sciences hub. In fact, the city boasted the third fastest-growing biotech community in the nation between 2014 and 2017, according to a CBRE report. Houstons biotech industry is gaining momentum due to an increase in funding as well. According to the Greater Houston Partnership, nearly $180 million in VC funding was allocated to the citys ecosystem of life sciences-related companies in 2019 alone.

Like many startups and tech companies across Houston, the citys life sciences leaders have been tackling some of the worlds most pressing issues. Whether theyre developing oncology drug candidates or advancing genomic medicine through the creation of sequencing technologies, the citys biotech organizations are pulling on decades of research and determination to transform the medical landscape on a global scale. Heres a look at 15 biotech companies in Houston making a major impact on medical research and discovery.

Founded: 2015

Focus: Canine Cancer Treatment

What they do:CAVU Biotherapiesprovides immune-based solutions to treat cancer and autoimmune diseases in dogs. The company offers an immune health monitoring service, which describes a dogs immune system through the use of a blood sample, as well as an autologous prescription product that retrains and expands a dogs T cells to recognize and fight cancer. CAVU Biotherapies ultimate aim is to use its immune-guided medicine to treat horses, cats, andeventually, humans.

Founded: 2006

Focus: Stem Cell Banking + Therapy

What they do: Founded by David Eller and Dr. Stanley Jones, Celltex Therapeutics focuses on developing stem cell therapies for a variety of conditions. The companys stem cell processing and banking methods are designed to ensure the genetic integrity and uniformity of an individuals cells in quantities necessary for therapeutic applications. Using proprietary technology, Celltex Therapeutics enables stem cells to be used for regenerative therapy for conditions like vascular, autoimmune and degenerative diseases.

Founded: 2006

Focus: Cell Therapy

What they do: InGeneron is a clinical stage cell therapy company that specializes in novel, evidence-based regenerative medicine therapies. The companys therapy is designed to repair injured tissue, improve the quality of life for patients and modify the progression of their disease. InGeneron focuses mainly on musculoskeletal indications such as pain management.

Founded: 2006

Focus: Cancer Treatment

What they do: Moleculin Biotech is a pharmaceutical company dedicated to the treatment of highly resistant cancers and viruses. The company develops oncology drug candidates for highly resistant tumors as well as as prodrug to exploit the potential uses of inhibitors of glycolysis. Guided by the aim to provide new hope to cancer patients, Moleculin Biotech focuses on discovering new treatments for acute myeloid leukemia, skin cancer, pancreatic cancer and brain tumors.

Founded: 2001

Focus: Nanomedicine

What they do: Nanospectra Biosciences is spearheading a patient-centric use of nanomedicine for the removal of cancerous tissues. The companys ultra-focal nanoshell technology is designed to thermally destroy solid tumors without damaging adjacent healthy tissue. Nanospectra Biosciences aims to maximize treatment efficacy while minimizing side effects associated with surgery, radiation and traditional focal therapies.

Founded: 2018

Focus: Cell Therapy

What they do: Marker Therapeutics is an immuno-oncology company that focuses on the development of next-generation T cell-based immunotherapies. With the aim of treating hematological malignancies and solid tumor indications, the company uses its own MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells. Marker Therapeutics is also working on developing proprietary DNA expression technology that is intended to improve the cellular immune systems ability to recognize and destroy diseased cells.

Founded: 2008

Focus: 3D Cell Culture

What they do: Nano3D Biosciences is dedicated to the development of 3D cell culture solutions. The companys core technology allows them to levitate or bioprint cells, which results in the formation of cultures that are more easily assembled and handled. Nano3D Biosciences products and services are intended for biomedical research, drug discovery, precision medicine, toxicology and regenerative medicine.

Founded: 2017

Focus: Small Molecule Inhibitors

What they do: Tvardi Therapeutics is a clinical-stage biotech company working on a new class of medicines for cancer, chronic inflammation and fibrosis. The company is focusing on the creation of orally delivered, small molecule inhibitors of STAT3, which is a key regulatory protein positioned at the intersection of many disease pathways. Tvardi Therapeutics is dedicated to delivering safe and effective solutions for use in the treatment of numerous diseases.

Founded: 2011

Focus: Targeted Cancer Therapies

What they do: Salarius Pharmaceuticals focuses on developing targeted therapies to treat various types of cancers. The companys lead candidate, Seclidemstat, is intended to treat Ewing sarcoma, a pediatric and young adult bone cancer that currently lacks targeted therapies. Salarius Pharmaceuticals performs clinical trials for the treatment of other advanced solid tumors including prostate, breast and ovarian cancers.

Founded: 2013

Focus: Genomic Medicine

What they do: Founded by Michael Metzker, RedVault Biosciences develops technologies with the aim of advancing genomic medicine. The company is currently working on a variety of projects including the development of sequencing technologies to determine haplotypes and structural variation in complex genomes. RedVault Biosciences is dedicated to identifying technology needs, creating and testing ideas, and transferring deliverables to production and distribution.

Founded: 2010

Focus: DNA Sequencing

What they do: Avance Biosciences focuses on assay development, assay validation and sample testing using next-generation DNA sequencing and other biological methods. The company offers biologics testing, diagnostic assay validation, GMO genomic testing, gene / cell therapy testing, digital and real-time PCR, microbial testing and more. Avance Biosciences aim is to assist its clients in advancing drug development and genomic research.

Founded: 2008

Focus: Bioremediation

What they do: Bionex Technology develops cost-effective, natural solutions for cleaning oil-polluted soil. The companys Super Microbe spill solution is naturally derived from microbes that digest and convert harmful contaminants on the ground and in soil, therefore lowering flammability, suppressing harmful vapors and creating a safer environment for spill responders. Bionex Technology offers a variety of other bioremediation products such as a customizable degreaser and detergent used for cleaning industrial tools.

Founded: 2016

Focus: Stem Cell Research

What they do: Located in nearby Sugar Land, Hope Biosciences is dedicated to developing stem cell-based therapies that are safe, effective and secure. The companys proprietary technology enables patients to make virtually unlimited and identical stem cells from their own tissue. Hope Biosciences offers stem cell banking solutions for both adults and newborns.

Founded: 2013

Focus: Interventional Cardiology

What they do: Saranas has created technology that enables the early detection and monitoring of bleeding complications associated with vascular access procedures. The companys monitoring system checks changes in the blood vessels electrical resistance before monitoring if bleeding has occurred from an unintentionally injured blood vessel. Saranas aims to allow physicians to mitigate downstream consequences by addressing bleeds before they become complications.

Founded: 1984

Focus: Microbiology

What they do: Microbiology Specialists Inc. specializes in microbiology testing, playing a role in microbial investigations and studies. The company also focuses on infectious disease diagnosis, forensic bacteriology and mycology, medical device testing and infection prevention. Microbiology Specialists Inc. is committed to delivering reliable, accurate and cost-effective microbiological results.

Read the original:
15 Biotech Companies In Houston To Know - Built In

The Global Cell Surface Markers Market is expected to grow from USD 561.02 Million in 2019 to USD 903.48 Million by the end of 2025 at a Compound…

June 18, 2020 23:52 ET | Source: ReportLinker

New York, June 18, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Cell Surface Markers Market Research Report by Product, by Source, by Cell Type, by Application, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p05913780/?utm_source=GNW On the basis of Product, the Cell Surface Markers Market is studied across Antibodies and Pcr Arrays.

On the basis of Source, the Cell Surface Markers Market is studied across Mice and Rats.

On the basis of Cell Type, the Cell Surface Markers Market is studied across B Cell Surface Markers, Monocyte Cell Surface Markers, NK Cell Surface Markers, and T Cell Surface Markers.

On the basis of Application, the Cell Surface Markers Market is studied across Clinical and Research. The Clinical further studied across Immunodeficiency Diseases and Oncology. The Research further studied across Drug Discovery, Immunology, and Stem Cell Research.

On the basis of End User, the Cell Surface Markers Market is studied across Academic & Research Institutes, Hospitals & Clinical Testing Laboratories, and Pharmaceutical & Biotechnology Companies.

On the basis of Geography, the Cell Surface Markers Market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region is studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region is studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region is studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles: The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Cell Surface Markers Market including Abcam, Becton, Dickinson and Company, Bio-Rad Laboratories, Bio-Techne, Biolegend, Cell Signaling Technology, Danaher Corporation, F. Hoffman-La Roche, Genscript, Merk KGaA, Qiagen N.V., and Thermo Fisher Scientific.

FPNV Positioning Matrix: The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cell Surface Markers Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window: The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

Cumulative Impact of COVID-19: COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

The report provides insights on the following pointers: 1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players 2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as: 1. What is the market size and forecast of the Global Cell Surface Markers Market? 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cell Surface Markers Market during the forecast period? 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cell Surface Markers Market? 4. What is the competitive strategic window for opportunities in the Global Cell Surface Markers Market? 5. What are the technology trends and regulatory frameworks in the Global Cell Surface Markers Market? 6. What are the modes and strategic moves considered suitable for entering the Global Cell Surface Markers Market? Read the full report: https://www.reportlinker.com/p05913780/?utm_source=GNW

About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Read the original:
The Global Cell Surface Markers Market is expected to grow from USD 561.02 Million in 2019 to USD 903.48 Million by the end of 2025 at a Compound...

Cell Freezing Media for Cell Therapy Market in COVID-19: Implications and Business Opportunities for Growth Globally – Cole of Duty

The research study Cell Freezing Media for Cell Therapy market 2020 launched by ABRReports.com provides the detailed analysis of the current market status, investment plans, production and consumption, price trends, and analysis by the market player, by region, by type, by application and etc, and custom research can be added according to specific requirements

Get Sample Copy of the report at https://www.abrreports.com/industry-insights/covid-19-impact-on-2020-2026-global-and-regional-cell-freezing-media-for-cell-therapy-industry-production-sales-and-consumption-status-and-prospects-professional-market-research-report-standard-version?form=request-report-sample

The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 50 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth.

The key players covered in the Cell Freezing Media for Cell Therapy Market research report are: By Market Players: BioLife Solutions Akron Biotechnology GE Healthcare Thermo Fisher Scientific Biological Industries Merck WAK-Chemie Medical Zenoaq

By Type With FBS Without FBS

By Application Human Embryonic Stem Cells CAR-T Cell Therapy Neural Stem Cell Therapy Mesenchymal Stem Cell Therapy Hematopoietic Stem Cell Transplantation Other

Click to access full report and Table of Content at https://www.abrreports.com/industry-insights/covid-19-impact-on-2020-2026-global-and-regional-cell-freezing-media-for-cell-therapy-industry-production-sales-and-consumption-status-and-prospects-professional-market-research-report-standard-version

The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.

Key pointers of the Table of Contents:

Chapter 1 Industry Overview Chapter 2 Global Cell Freezing Media for Cell Therapy Competition by Types, Applications, and Top Regions and Countries Chapter 3 Production Market Analysis Chapter 4 Global Cell Freezing Media for Cell Therapy Sales, Consumption, Export, Import by Regions (2015-2020) Chapter 5 North America Cell Freezing Media for Cell Therapy Market Analysis Chapter 6 East Asia Cell Freezing Media for Cell Therapy Market Analysis Chapter 7 Europe Cell Freezing Media for Cell Therapy Market Analysis Chapter 8 South Asia Cell Freezing Media for Cell Therapy Market Analysis Chapter 9 Southeast Asia Cell Freezing Media for Cell Therapy Market Analysis Chapter 10 Middle East Cell Freezing Media for Cell Therapy Market Analysis Chapter 11 Africa Cell Freezing Media for Cell Therapy Market Analysis Chapter 12 Oceania Cell Freezing Media for Cell Therapy Market Analysis Chapter 13 South America Cell Freezing Media for Cell Therapy Market Analysis Chapter 14 Company Profiles and Key Figures in Cell Freezing Media for Cell Therapy Business Chapter 15 Global Cell Freezing Media for Cell Therapy Market Forecast (2021-2026) Chapter 16 Conclusions

Purchase the research study @

https://www.abrreports.com/industry-insights/covid-19-impact-on-2020-2026-global-and-regional-cell-freezing-media-for-cell-therapy-industry-production-sales-and-consumption-status-and-prospects-professional-market-research-report-standard-version/checkout?option=one

About Us:

ABR Reports (Advanced Business Research Reports) is the premium market research reselling company that offers market research reports to individuals, organizations, and industries to enhance and strengthen the decision making process. With an associate thoroughgoing list of market research Publishers, we tend to cut across all the business verticals covering 5000+ micro markets and offer market size and share analysis, industry trends, information on products, regional market, and keen business insights to our clients.

Contact Us:

Scott Harris Sales Manager Email ID: [emailprotected] Phone No.: +1-561-448-7424

See the article here:
Cell Freezing Media for Cell Therapy Market in COVID-19: Implications and Business Opportunities for Growth Globally - Cole of Duty

The Global Cell Expansion Market is expected to grow from USD 13,177.29 Million in 2019 to USD 28,822.19 Million by the end of 2025 at a Compound…

June 19, 2020 01:32 ET | Source: ReportLinker

New York, June 19, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Cell Expansion Market Research Report by Product, by Cell Type, by Application, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p05913775/?utm_source=GNW The Consumables further studied across Disposables, Media, Reagents, and Sera. The Instruments further studied across Automated Cell Expansion System, Bioreactors, and Cell Expansion Supporting Equipment.

On the basis of Cell Type, the Cell Expansion Market is studied across Animal Cells and Human Cells. The Human Cells further studied across Differentiated Cells and Stem Cells.

On the basis of Application, the Cell Expansion Market is studied across Cancer and Cell-Based Research and Regenerative Medicine and Stem Cell Research.

On the basis of End User, the Cell Expansion Market is studied across Biotechnology & Biopharmaceutical Companies, Cell Banks, and Research Institutes.

On the basis of Geography, the Cell Expansion Market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region is studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region is studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region is studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles: The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Cell Expansion Market including Beckman Coulter Inc., Becton, Dickinson and Company, Corning Incorporated, GE Healthcare, Lonza Group LTD., Merck KGaA, Miltenyi Biotec, Promocell GmbH, Sartorius AG, Stemcell Technologies, Inc., Takara Bio Inc., Terumo BCT, and Thermo Fisher Scientific, Inc..

FPNV Positioning Matrix: The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cell Expansion Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window: The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

Cumulative Impact of COVID-19: COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

The report provides insights on the following pointers: 1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players 2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as: 1. What is the market size and forecast of the Global Cell Expansion Market? 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cell Expansion Market during the forecast period? 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cell Expansion Market? 4. What is the competitive strategic window for opportunities in the Global Cell Expansion Market? 5. What are the technology trends and regulatory frameworks in the Global Cell Expansion Market? 6. What are the modes and strategic moves considered suitable for entering the Global Cell Expansion Market? Read the full report: https://www.reportlinker.com/p05913775/?utm_source=GNW

About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Continue reading here:
The Global Cell Expansion Market is expected to grow from USD 13,177.29 Million in 2019 to USD 28,822.19 Million by the end of 2025 at a Compound...